Health Tech Sees Robust Funding in June, Highlighting AI's Role in Patient Care

Health tech companies continued to attract substantial investments in June, with several notable funding announcements reflecting the sector's rapid growth and the increasing role of artificial intelligence (AI) in patient care. The month saw four major funding rounds that collectively raised over $340 million, highlighting investor confidence in these innovative solutions.

Assort Health Raises $120 Million in Series C Funding

Assort Health, an AI platform supporting various aspects of patient care including scheduling, intake, referrals, document processing, medication refills, and payments, announced a significant funding round. The Series C, totaling $120 million, was led by Menlo Ventures with participation from Lightspeed Venture Partners, Felicis, First Round Capital, Chemistry, Joe Montana, Tau Ventures, and Quiet Capital. This brings Assort Health's total funding to $222 million, valuing the company at $1.2 billion.

The platform is built on over 190 million patient interactions, making it one of the most data-rich AI solutions in the healthcare market. The new funds will be used to scale its operations and expand its deployment of AI agents across various stages of the patient journey.

Cadence Secures $100 Million in Series C Funding

Cadence, a clinical AI company focused on chronic disease management, also announced a major funding round this June. The Series C, which raised $100 million, was led by Spark Capital and included participation from Thrive Capital, General Catalyst, Coatue, B Capital, Corewell Health Ventures, Memorial Hermann, and Duke Health.

Cadence's AI technology helps monitor patients, identify risks, and coordinate interventions, working with over 20 health systems and serving more than 100,000 patients. The funding will support the company's expansion into new health systems and further enhance its AI capabilities to improve patient outcomes.

Market Trends in Health Tech Funding

The robust funding rounds for Assort Health and Cadence reflect broader trends in the health tech sector. According to a recent report by CB Insights, health tech startups raised over $20 billion globally in 2025, with AI-driven solutions accounting for a significant portion of this investment.

Investors are increasingly recognizing the potential of AI to transform healthcare delivery. By automating routine tasks and providing data-driven insights, these technologies can improve patient outcomes, reduce costs, and enhance the overall efficiency of healthcare systems. The growing adoption of telemedicine and remote monitoring further underscores the importance of AI in modern healthcare.

Adaptive Innovations Raises $60 Million in Series A Funding

Adaptive Innovations, an AI operating system for home health care, secured a $60 million funding round this June. The company combines AI operations with in-home clinicians to provide personalized care, having launched in 2025 and already provided over 100,000 patient visits while partnering with more than 500 referring healthcare organizations.

The Series A round was led by a consortium of investors, including several prominent venture capital firms. The funds will be used to expand the company's reach and enhance its AI platform, further solidifying its position in the home health care market.

Investment Implications

The significant funding rounds for Assort Health, Cadence, and Adaptive Innovations highlight the growing investor interest in health tech companies that leverage AI to improve patient care. These investments not only validate the potential of these technologies but also signal a shift towards more data-driven and efficient healthcare delivery models.

For investors, the health tech sector offers promising opportunities with high growth potential. However, it is important to carefully evaluate the competitive landscape, regulatory environment, and technological capabilities of individual companies. The successful integration of AI into healthcare operations could lead to substantial returns, but it also comes with inherent risks such as data privacy concerns and the need for continuous innovation.

As the health tech market continues to evolve, investors should monitor key performance indicators and stay informed about emerging trends and advancements in AI technology. The companies that can effectively scale their solutions and demonstrate tangible benefits will likely be well-positioned for long-term success.